Blincyto Kit
Product Images NDC 55513-160

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Blincyto (NDC 55513-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Kaplan Meier Curve Of Overall Survival In Tower Study (Blincyto 01)

Not available. The text appears to be a mix of numbers, symbols, and a few words/abbreviations that do not provide any discernible meaning or context.*

FDA Label Image

Blincyto 02

This is a medication label for YABLINCYTO (blinatumomab) in vial form for intravenous infusion. It is stored at a temperature range between 2°C and 8°C and should be protected from light. The medication is administered through intravenous infusion only. It also includes instructions not to shake the reconstituted solution and to discard any unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.